What is the appropriate ICD‑10 code for a patient who needs a hepatitis B serologic titer?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 23, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

ICD-10 Code for Hepatitis B Titer Testing

Use ICD-10 code Z11.59 (Encounter for screening for other viral diseases) for ordering hepatitis B serologic titers in asymptomatic patients requiring screening or immunity assessment.

Primary Coding Options

For patients needing hepatitis B titer testing, the appropriate ICD-10 code depends on the clinical context:

Screening/Immunity Assessment

  • Z11.59 - Encounter for screening for other viral diseases
    • Use when checking immunity status post-vaccination
    • Use for routine screening in at-risk populations
    • Use for pre-vaccination screening

Alternative Codes Based on Clinical Context

  • Z23 - Encounter for immunization

    • When titer is drawn specifically to determine need for vaccination
  • Z20.5 - Contact with and (suspected) exposure to viral hepatitis

    • When testing follows known exposure to hepatitis B
  • Z86.19 - Personal history of other infectious and parasitic diseases

    • When checking for resolved infection in patients with prior hepatitis B history

Clinical Context for Testing

The guidelines indicate several scenarios requiring hepatitis B serologic testing 1, 2:

High-risk populations requiring screening include:

  • Persons born in endemic areas (HBsAg prevalence ≥2%)
  • Healthcare workers and first responders
  • Persons with HIV infection
  • Household and sexual contacts of HBsAg-positive persons
  • Persons who inject drugs
  • Men who have sex with men
  • Dialysis patients
  • Pregnant women
  • Immunosuppressed patients (including those on chemotherapy)

Post-vaccination testing indications:

  • Immunocompromised patients 1-2 months after completing vaccine series 2
  • Healthcare workers requiring documentation of immunity
  • Patients with special conditions (HIV-infected, dialysis patients)

Important Coding Considerations

Do not use diagnostic codes (B18.0, B18.1, B19.1) when simply ordering titers for screening purposes, as these indicate confirmed chronic hepatitis B infection 3, 4.

Postvaccination testing is NOT recommended for healthy individuals 2. Testing should be reserved for those with occupational exposure risk or immunocompromising conditions.

The serologic markers typically ordered include 1:

  • HBsAg (hepatitis B surface antigen)
  • Anti-HBs (antibody to HBsAg) - indicates immunity
  • Anti-HBc (antibody to hepatitis B core antigen)

For billing purposes, ensure documentation clearly states the reason for testing (screening, post-vaccination immunity check, exposure assessment) to support the ICD-10 code selection and medical necessity.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.